After having a liver transplant Steve Jobs is reported to have an “excellent prognosis” by the medical institute responsible for the operation. Nice to hear some good news surrounding a pancreatic cancer survivor, even if he is one with the means to pay for the very best in medical care.
The Methodist University Hospital Transplant Institute also issued a statement with the prognosis claiming Jobs received his liver because he was “the sickest patient on the waiting list at the time a donor organ became available.” This was no doubt released to allay concerns that Jobs may have seen special treatment because of status.
Good news for Jobs means good news for Apple, whose stock dropped some 10 points when the CEO announced his leave of absence in January. There had been speculation about his health leading up to the announcement, though Jobs claimed it was a hormone imbalance until he finally had to leave.
Despite his absence, Apple stock has continued to blow up, surging 60% this year alone. Hopefully we’ll see Jobs taunting handicapped grandmothers in his Cupertino parking lot soon.
